Evidence map›Paper›PMID 9512511›Full record

ArticleGenes & development1998

Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway.

T Miyazaki, A Takaoka, L Nogueira, I Dikic, H Fujii, S Tsujino, Y Mitani, M Maeda, J Schlessinger, T Taniguchi

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Cell type-specific roles of Jak3 in IL-2-induced proliferative signal transduction.Biochemical and biophysical research communications · 2007
    Article
  15. Article
  16. Review
  17. Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

T MiyazakiDepartment of Immunology, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, 113, Japan.
A Takaoka
L Nogueira
I Dikic
H Fujii
S Tsujino
Y Mitani
M Maeda
J Schlessinger
T Taniguchi
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many cytokines transmit signals to the cell interior through activation of receptor-associated, Janus family protein tyrosine kinases (Jak PTKs). The interleukin-2 receptor (IL-2R) is associated with the Jak1 and Jak3 PTKs, and ligand-induced activation of these PTKs is essential for lymphocyte proliferation. Here, the nonreceptor PTK, Pyk2, was found to be activated following IL-2 stimulation in a Jak-dependent manner. Furthermore, physical association was detected between endogenous Pyk2 and Jak3, and a dominant interfering mutant of Pyk2 inhibited IL-2-induced cell proliferation without affecting Stat5 activation. Collectively, these results suggest that Pyk2 is a newly identified component of the Jak-mediated IL-2 signaling pathway.

Indexed as

Milk ProteinsBinding SitesCell DivisionCells, CulturedDNA-Binding ProteinsEnzyme ActivationFocal Adhesion Kinase 2HumansInterleukin-2Janus Kinase 3Protein-Tyrosine KinasesReceptors, Interleukin-2Signal TransductionSTAT5 Transcription FactorTrans-ActivatorsDNA-Binding ProteinsFocal Adhesion Kinase 2Interleukin-2JAK3 protein, humanJanus Kinase 3Milk ProteinsProtein-Tyrosine KinasesReceptors, Interleukin-2STAT5 Transcription FactorTrans-Activators

Identifiers

PMID9512511
PMCPMC316631
OpenAlexW2119228709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.